Author:
Creemers A.,Krausz S.,Strijker M.,van der Wel M.J.,Soer E.C.,Reinten R.J.,Besselink M.G.,Wilmink J.W.,van de Vijver M.J.,van Noesel C.J.M.,Verheij J.,Meijer S.L.,Dijk F.,Bijlsma M.F.,van Oijen M.G.H.,van Laarhoven H.W.M.
Subject
Cancer Research,Genetics,Oncology
Reference63 articles.
1. Molecular-pathological prognostic factors of gastric cancer: a review;Yasui;Gastric Cancer,2005
2. A “catastrophic hypothesis” for pancreas cancer progression;Real;Gastroenterology,2003
3. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: scientific review;Shaheen,2002
4. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial;Neoptolemos;Lancet,2017
5. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer;Goonetilleke;Eur. J. Surg. Oncol.,2007
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献